Search results for “Malignant Brenner tumor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 69 patents, we discovered top 35 key players by total patent application. Active Biotech AB, EXACT Sciences Corp., Shionogi & Co., Ltd. are dominant in this area. They take 28.99% of the total patent filing.
Sweden
Patent: 12
Wisconsin, United States
Patent: 4
Osaka-fu, Japan
Patent: 3
Tokyo-to, Japan
Patent: 3
United Kingdom
Patent: 3
Japan
Patent: 3
Tokyo-to, Japan
Patent: 2
Tokyo-to, Japan
Patent: 2
Washington, United States
Patent: 2
United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 38 patents, we discovered top 12 universities and scientific research institutions by total patent application. Nihon University, Osaka University, Universidad Autónoma de Madrid are dominant in this area. They take 21.05% of the total patent filing.
Tokyo-to, Japan
Patent: 3
Osaka-fu, Japan
Patent: 2
Madrid, Spain
Patent: 2
New York, United States
Patent: 1
United States
Patent: 1
Minnesota, United States
Patent: 1
North Carolina, United States
Patent: 1
Tokyo-to, Japan
Patent: 1
Hokkaido, Japan
Patent: 1
Hong Kong SAR, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: